Tag: genomics
-
Microbiome Therapies Company Unveils, Raises $50M
A new enterprise is underway developing therapeutics targeting bacterial communities in the body, to treat metabolic disorders and cancer.
-
Heart Disease Biotech Acquired in $13.1B Deal
A company developing precision medicine drugs to treat inherited heart disorders was acquired by drug maker Bristol Myers Squibb, or BMS, for $13.1 billion.
-
Biotech, Analytics Companies Partner on Drug Discovery
A biotechnology company and genomics data science enterprise agreed in a multi-year agreement to discover new therapies for up to 20 diseases.
-
DoD Funds Covid-19 G.I. Infection Therapy
A biotechnology company is developing biologic treatments for Covid-19 infections in the gastrointestinal tract and to block further disease transmission.
-
Chip-Based RNA Biotech Raises $60M in Venture Funds
A company developing messenger RNA therapeutics on demand from single-use biochips is raising $60 million in its second venture funding round.
-
Quick Crispr-Based Test Detects Malaria in Blood
A blood test designed for low-resource field settings is shown to quickly detect and distinguish between different malaria parasites needed to accurately diagnose the disease.
-
Cancer Screening Analytics Company Acquired in $8B Deal
A company creating a blood test to screen for multiple types of cancer is being acquired by genomics analytics company Illumina for $8 billion in cash and stock.
-
Biotechs Partner on Gene-Editing Cystic Fibrosis Therapy
Two biotechnology companies are adding to their current collaboration to develop delivery techniques for gene-editing treatments for cystic fibrosis.
-
Precision Cancer Therapy Start-Up Gains $110M in Early Funds
A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round.
-
Synthetic Antibodies Neutralize Covid-19 Virus Proteins
A company developing synthetic genetic materials and proteins says independent tests show its artificial antibodies neutralize infection mechanisms in Covid-19 viruses.